Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÅK Söderqvist, J Fransén… - Journal of …, 2016 - jnis.bmj.com
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …
被引用次数：26 相关文章
[HTML] nih.gov

[HTML][HTML] Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÅK Söderqvist, J Fransén… - Journal of …, 2016 - ncbi.nlm.nih.gov
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …

Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis.

A Falk-Delgado, J Fransén - Journal of Neurointerventional …, 2015 - europepmc.org
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …

Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÅK Söderqvist… - Journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …

Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÃK Söderqvist… - Journal of …, 2016 - search.proquest.com
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …

Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, Å Kuntze Söderqvist… - Journal of …, 2016 - diva-portal.org
BACKGROUND AND PURPOSE: Intravenous thrombolysis with tissue plasminogen
activator is standard treatment in acute stroke today. The benefit of endovascular treatment …
[PDF] cyberleninka.org

[PDF][PDF] Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÅK Söderqvist, J Fransén… - cyberleninka.org
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …
[PDF] researchgate.net

[PDF][PDF] Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÅK Söderqvist, J Fransén… - researchgate.net
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …
[PDF] bmj.com

[PDF][PDF] Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis

A Falk-Delgado, ÅK Söderqvist, J Fransén… - Journal of …, 2015 - jnis.bmj.com
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …

Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis.

A Falk-Delgado, J Fransén - Journal of Neurointerventional …, 2015 - europepmc.org
Background and purpose Intravenous thrombolysis with tissue plasminogen activator is
standard treatment in acute stroke today. The benefit of endovascular treatment has been …